SCHEMBL212723

SCHEMBL212723

O=C(O)C1=COc2ccccc2C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.42
MAOB P27338 2/20 0.42
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
HSD17B10 Q99714 2/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
NOTUM Q6P988 1/20 0.36
SRD5A2 P31213 2/20 0.35
ACSL1 P33121 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33
OXTR P30559 1/20 0.32
DAO P14920 1/20 0.32
TSHR P16473 1/20 0.32
NAPRT Q6XQN6 1/20 0.32
ALOX15 P16050 1/20 0.32
ALPL P05186 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16397646 1.00 MAOA (0.42) MAOAMAOBALDH1A1KDM4EHSD17B10
SCHEMBL2230058 0.84 MAOA (0.41) MAOAMAOBALDH1A1KDM4EHSD17B10
SCHEMBL9058873 0.84 MAOA (0.41) MAOAMAOBALDH1A1KDM4EGAA
Trifluoroacetic Acid SCHEMBL16669664 0.78 MAOA (0.33) MAOAMAOBALDH1A1KDM4EHSD17B10
SCHEMBL4539282 0.76 MAOA (0.41) MAOAMAOBOXTR
SCHEMBL6818277 0.76 SRD5A1 (0.41) ALDH1A1NOTUMSRD5A2TSHRALOX15
SCHEMBL4537383 0.76 TSHR (0.45) ALDH1A1KDM4EHSD17B10GAAHPGD
SCHEMBL29351770 0.76 TSHR (0.45) ALDH1A1KDM4EHSD17B10GAAHPGD
SCHEMBL8665717 0.74 AKR1B1 (0.38) MAOAMAOBKDM4EGAAHPGD
SCHEMBL2708309 0.74 MAOA (0.38) MAOAMAOBALDH1A1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4297874-A1 NONAUTOLOGOUS MULTI-STRESSED CANCER CELLS AND USES THEREOF FOR VACCINATING AND TREATING CANCERS BRENUS PHARMA (FR) 2024-01-03 EP claimed
CN-116730967-A Synthesis method of chroman-3-formic acid 安徽大学 2023-09-12 CN claimed
WO-2022180251-A1 NONAUTOLOGOUS MULTI-STRESSED CANCER CELLS AND USES THEREOF FOR VACCINATING AND TREATING CANCERS BRENUS PHARMA (FR) 2022-09-01 WO claimed
CN-106928046-B A kind of salicylic preparation method of 3,4,5,6- tetrafluoro 常州佳德医药科技有限公司 2019-10-18 CN claimed
CN-105636943-B Chromene derivatives as inhibitors of the TCR-Nck interaction 阿塔克斯生物制药有限公司 2019-01-22 CN claimed
CN-106632190-B 7-(diethylamino) -2- oxo -2H- chromene -3- carboxylic acid preparation method 山西大学 2018-12-07 CN claimed
CN-107868069-A The preparation technology of the carboxylic acid of 7 hydroxyl, 8 methyl, 6 nitro, 2 oxygen 2H chromenes 3 山东新华制药股份有限公司 2018-04-03 CN claimed
CN-105541774-A 3,4-dihydrocoumarin compound and preparation method and application thereof UNIV HUAZHONG 2016-05-04 CN claimed
EP-2601183-A1 COUMARIN-CHALCONES AS ANTICANCER AGENTS Council Of Scientific & Industrial Research (IN) 2013-06-12 EP claimed
WO-2012017454-A1 COUMARIN-CHALCONES AS ANTICANCER AGENTS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2012-02-09 WO claimed
EP-1643995-A1 TREATMENT OF MIGRAINE ACCOMPANIED BY NAUSEA Pharmacia Corporation (US) 2006-04-12 EP claimed
EP-1631562-A1 CHROMENE DERIVATIVES AS ANTI-INFLAMMATORY AGENTS Pharmacia Corporation (US) 2006-03-08 EP claimed
EP-1572186-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF HERPES VIRUS INFECTIONS USING CYCLOOXYGENASE-2 SELECTIVE INHIBITORS OR CYCLOOXYGENASE-2 INHIBITORS IN COMBINATION WITH ANTIVIRAL AGENTS Pharmacia Corporation (US) 2005-09-14 EP claimed
WO-2005000294-A1 SELECTIVE INHIBITOR AND AN ANTICONVULSANT AGENT FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS PHARMACIA CORPORATION (US) 2005-01-06 WO claimed
WO-2005000297-A1 TREATMENT OF MIGRAINE ACCOMPANIED BY NAUSEA PHARMACIA CORPORATION (US) 2005-01-06 WO claimed
WO-2004093816-A2 COMPOSITIONS COMPRISING A SELECTIVE COX-2 INHIBITOR AND A CALCIUM MODULATING AGENT PHARMACIA CORPORATION (US) 2004-11-04 WO claimed
WO-2004087687-A1 CHROMENE DERIVATIVES AS ANTI-INFLAMMATORY AGENTS PHARMACIA CORPORATION (US) 2004-10-14 WO claimed
WO-2004056349-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF HERPES VIRUS INFECTIONS USING CYCLOOXYGENASE-2 SELECTIVE INHIBITORS OR CYCLOOXYGENASE-2 INHIBITORS IN COMBINATION WITH ANTIVIRAL AGENTS PHARMACIA CORPORATION (US) 2004-07-08 WO claimed
EP-0977748-A1 SUBSTITUTED BENZOPYRAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 2000-02-09 EP claimed
WO-1998047890-A1 SUBSTITUTED BENZOPYRAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-10-29 WO claimed